Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial.
William JacotAntoine ArnaudMarta JarlierClaudia Lefeuvre-PlessePhilippe DalivoustPierre SenesseAhmed AzzedineOlivier TredanSophie Sadot-LebouvierSébastien MasMarion CarayolJean-Pierre BleuseSophie GourgouChloé JaniszewskiSilene LaunayVéronique D'HondtGéraldine LauridantJulien GrenierGilles RomieuGregory NinotLaurence VanlemmensPublished in: Nutrients (2020)
Supervised exercise dietary programs are recommended to relieve cancer-related fatigue and weight increase induced by adjuvant treatment of early breast cancer (EBC). As this recommendation lacks a high level of evidence, we designed a multicenter randomized trial to evaluate the impact of an Adapted Physical Activity Diet (APAD) education program on fatigue. We randomized 360 women with EBC who were receiving adjuvant chemotherapy and radiotherapy to APAD or usual care at eight French cancer institutions. Data were collected at baseline, end of chemotherapy, end of radiotherapy, and 6 months post-treatment. The primary endpoint was the general cancer-related fatigue score using the MFI-20 questionnaire. Fatigue correlated with the level of precariousness, but we found no significant difference between the two groups in terms of general fatigue (p = 0.274). The APAD arm has a smaller proportion of patients with confirmed depression at the end of follow-up (p = 0.052). A transient modification in physical activity levels and dietary intake was reported in the experimental arm. However, a mixed hospital- and home-based APAD education program is not enough to improve fatigue caused by adjuvant treatment of EBC. Cancer care centers should consider integrating more proactive diet-exercise supportive care in this population, focusing on precarious patients.
Keyphrases
- physical activity
- sleep quality
- healthcare
- early stage
- randomized controlled trial
- quality improvement
- weight loss
- body mass index
- cancer therapy
- double blind
- palliative care
- locally advanced
- radiation therapy
- depressive symptoms
- end stage renal disease
- ejection fraction
- emergency department
- early breast cancer
- drug delivery
- chronic kidney disease
- young adults
- rectal cancer
- combination therapy
- clinical trial
- squamous cell carcinoma
- pain management
- big data
- acute care
- papillary thyroid
- health insurance
- prognostic factors
- phase ii
- deep learning
- childhood cancer